Dr. Emese Zsiros
Claim this profileRoswell Park Cancer Institute
Studies Ovarian Cancer
Studies Ovarian Tumors
10 reported clinical trials
17 drugs studied
Area of expertise
1Ovarian Cancer
Stage IV
Stage III
Stage II
2Ovarian Tumors
Stage IV
Stage III
Stage II
Affiliated Hospitals
Clinical Trials Emese Zsiros is currently running
APL-2 + Pembrolizumab +/- Bevacizumab
for Ovarian Cancer
This trial tests APL-2 alone or with other drugs in patients with recurrent ovarian, fallopian tube, or primary peritoneal cancer that causes fluid buildup. APL-2 aims to slow tumor growth, reduce fluid buildup, and enhance the immune response. The study aims to determine the most effective treatment.
Recruiting1 award Phase 212 criteria
Letrozole +/- Chemotherapy
for Ovarian Cancer
This phase III trial studies how well letrozole with or without paclitaxel and carboplatin works in treating patients with stage II-IV low-grade serous carcinoma of the ovary, fallopian tube, or peritoneum. Letrozole is an enzyme inhibitor that lowers the amount of estrogen made by the body which in turn may stop the growth of tumor cells that need estrogen to grow. Drugs used in chemotherapy, such as paclitaxel and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether giving letrozole alone or in combination with paclitaxel and carboplatin works better in treating patients with low-grade serous carcinoma of the ovary, fallopian tube, or peritoneum compared to paclitaxel and carboplatin without letrozole.
Recruiting2 awards Phase 318 criteria
More about Emese Zsiros
Clinical Trial Related3 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Emese Zsiros has experience with
- Pembrolizumab
- Nivolumab
- Ipilimumab
- Bevacizumab
- NC762
- Autologous Natural Killer Cell-like CTLs
Breakdown of trials Emese Zsiros has run
Ovarian Cancer
Ovarian Tumors
Fallopian Tube Cancer
Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Emese Zsiros specialize in?
Emese Zsiros focuses on Ovarian Cancer and Ovarian Tumors. In particular, much of their work with Ovarian Cancer has involved Stage IV patients, or patients who are Stage III.
Is Emese Zsiros currently recruiting for clinical trials?
Yes, Emese Zsiros is currently recruiting for 6 clinical trials in Buffalo New York. If you're interested in participating, you should apply.
Are there any treatments that Emese Zsiros has studied deeply?
Yes, Emese Zsiros has studied treatments such as Pembrolizumab, Nivolumab, Ipilimumab.
What is the best way to schedule an appointment with Emese Zsiros?
Apply for one of the trials that Emese Zsiros is conducting.
What is the office address of Emese Zsiros?
The office of Emese Zsiros is located at: Roswell Park Cancer Institute, Buffalo, New York 14263 United States. This is the address for their practice at the Roswell Park Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.